GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PW Medtech Group Ltd (FRA:PWE) » Definitions » ROE % Adjusted to Book Value

PW Medtech Group (FRA:PWE) ROE % Adjusted to Book Value : 17.00% (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is PW Medtech Group ROE % Adjusted to Book Value?

PW Medtech Group's ROE % for the quarter that ended in Dec. 2023 was 4.08%. PW Medtech Group's PB Ratio for the quarter that ended in Dec. 2023 was 0.24. PW Medtech Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 17.00%.


PW Medtech Group ROE % Adjusted to Book Value Historical Data

The historical data trend for PW Medtech Group's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PW Medtech Group ROE % Adjusted to Book Value Chart

PW Medtech Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.53 25.25 54.91 15.94 15.54

PW Medtech Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.75 14.45 13.35 26.85 17.00

Competitive Comparison of PW Medtech Group's ROE % Adjusted to Book Value

For the Medical Instruments & Supplies subindustry, PW Medtech Group's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PW Medtech Group's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where PW Medtech Group's ROE % Adjusted to Book Value falls into.



PW Medtech Group ROE % Adjusted to Book Value Calculation

PW Medtech Group's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=3.73% / 0.24
=15.54%

PW Medtech Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=4.08% / 0.24
=17.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PW Medtech Group ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of PW Medtech Group's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


PW Medtech Group (FRA:PWE) Business Description

Traded in Other Exchanges
Address
Building 1, No. 23 Panlong West Road, Pinggu District, Beijing, CHN, 101204
PW Medtech Group Ltd is a medical device company with a focus on fast-growing and high-margin segments of China's medical device industry. The company is engaged in the research and development, manufacturing, and sale of the advanced infusion set, intravenous cannula products, and insulin needles. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens. The company operates through three business segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business.

PW Medtech Group (FRA:PWE) Headlines

No Headlines